1. Home
  2. APAM vs RYTM Comparison

APAM vs RYTM Comparison

Compare APAM & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APAM
  • RYTM
  • Stock Information
  • Founded
  • APAM 1994
  • RYTM 2008
  • Country
  • APAM United States
  • RYTM United States
  • Employees
  • APAM N/A
  • RYTM N/A
  • Industry
  • APAM Investment Managers
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • APAM Finance
  • RYTM Health Care
  • Exchange
  • APAM Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • APAM 3.3B
  • RYTM 3.1B
  • IPO Year
  • APAM 2013
  • RYTM 2017
  • Fundamental
  • Price
  • APAM $46.68
  • RYTM $56.23
  • Analyst Decision
  • APAM Hold
  • RYTM Strong Buy
  • Analyst Count
  • APAM 4
  • RYTM 10
  • Target Price
  • APAM $44.13
  • RYTM $62.30
  • AVG Volume (30 Days)
  • APAM 477.9K
  • RYTM 661.2K
  • Earning Date
  • APAM 10-29-2024
  • RYTM 11-05-2024
  • Dividend Yield
  • APAM 7.03%
  • RYTM N/A
  • EPS Growth
  • APAM 18.41
  • RYTM N/A
  • EPS
  • APAM 3.60
  • RYTM N/A
  • Revenue
  • APAM $1,063,748,000.00
  • RYTM $112,530,000.00
  • Revenue This Year
  • APAM $15.88
  • RYTM $63.95
  • Revenue Next Year
  • APAM $9.20
  • RYTM $43.24
  • P/E Ratio
  • APAM $12.97
  • RYTM N/A
  • Revenue Growth
  • APAM 11.72
  • RYTM 81.55
  • 52 Week Low
  • APAM $36.45
  • RYTM $31.53
  • 52 Week High
  • APAM $49.52
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • APAM 54.37
  • RYTM 51.46
  • Support Level
  • APAM $46.54
  • RYTM $47.61
  • Resistance Level
  • APAM $48.11
  • RYTM $68.58
  • Average True Range (ATR)
  • APAM 1.23
  • RYTM 3.32
  • MACD
  • APAM 0.05
  • RYTM 0.27
  • Stochastic Oscillator
  • APAM 52.51
  • RYTM 41.11

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

Share on Social Networks: